Literature DB >> 28247152

Magnetic resonance imaging study of cryptococcal neuroradiological lesions in HIV-negative cryptococcal meningitis.

Y Zhong1, Z Zhou1, X Fang1, F Peng2, W Zhang3.   

Abstract

Magnetic resonance (MR) scanning has become an important diagnostic and management tool in cryptococcal meningitis (CM). However, there are only isolated case reports documenting neuroradiological findings in human immunodeficiency virus (HIV)-negative patients with CM and none has clearly addressed the relationship between cerebral lesions on magnetic resonance imaging (MRI) and prognosis. The MR brain images available from 114 HIV-negative patients with CM were retrospectively analysed. Patients were divided into Group I with one or more CM-related lesions and Group II without CM-related lesions. Initial clinical and biochemical markers and prognosis were collected and compared between the two groups. In the present study, the most common pattern of CM-related lesions by MRI was radiological meningitis, following by Virchow-Robin (VR) dilatation, hydrocephalus, intracerebral nodules and pseudocysts, which was different from previous studies reporting that the main MR findings of cerebral cryptococcosis in HIV-infected patients include dilated VR spaces, masses and pseudocysts. Compared to the patients without CM-related lesions, patients with CM-related lesions presented with a higher percentage of male patients, a higher frequency of altered mental status, a higher positive rate of Cryptococcus culture in cerebrospinal fluid (CSF) and a lower ratio of CSF glucose/blood glucose. Poor outcomes were more frequent in patients with presence of CM-related lesions compared to patients without CM-related lesions. In conclusion, the main pattern of cryptococcosis-related lesions on MR scanning differ between non-HIV- and HIV-positive patients with CM. The presence of CM-related lesions was significantly associated with predictors for poor outcome. Neuroimaging on MR scanning is a useful tool to evaluate the initial severity and prognosis of CM without HIV infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28247152     DOI: 10.1007/s10096-017-2941-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  33 in total

1.  The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.

Authors:  Sara A Mirza; Maureen Phelan; David Rimland; Edward Graviss; Richard Hamill; Mary E Brandt; Tracie Gardner; Matthew Sattah; Gabriel Ponce de Leon; Wendy Baughman; Rana A Hajjeh
Journal:  Clin Infect Dis       Date:  2003-02-27       Impact factor: 9.079

2.  Cerebrospinal fluid/blood glucose ratio as an indicator for bacterial meningitis.

Authors:  Hidetaka Tamune; Hiroaki Takeya; Wakako Suzuki; Yasuaki Tagashira; Takaie Kuki; Hitoshi Honda; Mitsuhiro Nakamura
Journal:  Am J Emerg Med       Date:  2013-11-26       Impact factor: 2.469

3.  CT of intracranial cryptococcosis.

Authors:  M J Popovich; R H Arthur; E Helmer
Journal:  AJR Am J Roentgenol       Date:  1990-03       Impact factor: 3.959

4.  Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.

Authors:  R A Larsen; M A Leal; L S Chan
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

5.  Cryptococcal choroid plexitis as a mass lesion: MR imaging and histopathologic correlation.

Authors:  Jerry M E Kovoor; Anita Mahadevan; Jayakumar P Narayan; Srikanth S Govindappa; P Satishchandra; Anisya V Taly; S K Shankar
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

6.  [Prognosis factors in cryptococcal meningoencephalitis].

Authors:  C Darzé; R Lucena; I Gomes; A Melo
Journal:  Arq Neuropsiquiatr       Date:  1999-09       Impact factor: 1.420

7.  Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitis.

Authors:  A Loyse; A Moodley; P Rich; S F Molloy; T Bicanic; L Bishop; W I D Rae; A I Bhigjee; N D Loubser; A J Michowicz; D Wilson; T S Harrison
Journal:  J Infect       Date:  2014-10-22       Impact factor: 6.072

8.  Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis.

Authors:  S R Jakka; S Veena; R M Atmakuri; M Eisenhut
Journal:  Cerebrospinal Fluid Res       Date:  2006-06-09

9.  A retrospective study of contributing factors for prognosis and survival length of cryptococcal meningoencephalitis in Southern part of China (1998-2013).

Authors:  Hui Zheng; Mingyue Li; Yingting Luo; Dongmei Wang; Jialing Yang; Qiong Chen; Junying Lao; Ningfen Chen; Man Yang; Qun Wang
Journal:  BMC Infect Dis       Date:  2015-02-19       Impact factor: 3.090

10.  Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Authors:  Françoise Dromer; Simone Mathoulin-Pélissier; Odile Launay; Olivier Lortholary
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

View more
  6 in total

1.  Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France.

Authors:  Laurène Tardieu; Gillian Divard; Olivier Lortholary; Anne Scemla; Éric Rondeau; Isabelle Accoceberry; Rémi Agbonon; Alexandre Alanio; Adela Angoulvant; Laetitia Albano; Philippe Attias; Anne Pauline Bellanger; Dominique Bertrand; Julie Bonhomme; Françoise Botterel; Nicolas Bouvier; Matthias Buchler; Taieb Chouaki; Thomas Crépin; Marie-Fleur Durieux; Guillaume Desoubeaux; Gary Doppelt; Loïc Favennec; Arnaud Fekkar; Ophélie Fourdinier; Marie Frimat; Jean-Pierre Gangneux; Claire Garandeau; Lilia Hasseine; Christophe Hennequin; Xavier Iriart; Nassim Kamar; Hannah Kaminski; Raphael Kormann; Laurence Lachaud; Christophe Legendre; Moglie Le Quintrec Donnette; Jordan Leroy; Charlène Levi; Marie Machouart; David Marx; Jean Menotti; Valérie Moal; Florent Morio; Natacha Mrozek; Muriel Nicolas; Philippe Poirier; Marie-Noelle Peraldi; Benjamin Poussot; Stéphane Ranque; Jean-Philippe Rerolle; Boualem Sendid; Renaud Snanoudj; Jérôme Tourret; Marc Vasse; Cécile Vigneau; Odile Villard; Laurent Mesnard; Fanny Lanternier; Cédric Rafat
Journal:  Pathogens       Date:  2022-06-17

2.  Choroid Plexitis and Ependymitis by Magnetic Resonance Imaging are Biomarkers of Neuronal Damage and Inflammation in HIV-negative Cryptococcal Meningoencephalitis.

Authors:  Dima A Hammoud; Eman Mahdi; Anil A Panackal; Paul Wakim; Virginia Sheikh; Irini Sereti; Bibi Bielakova; John E Bennett; Peter R Williamson
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

3.  Intrathecal IgG Synthesis and Persistent Inflammation Are Associated with White Matter Lesions in HIV-negative Patients with Cryptococcal Meningoencephalitis.

Authors:  Masaki Ohyagi; Takashi Irioka; Takuya Ohkubo; Satoru Ishibashi; Yuko K Takahashi; Eiichiro Amano; Akira Machida; Hiroya Kuwahara; Takanori Yokota
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

4.  Cryptococcus Meningitis Can Co-occur with Anti-NMDA Receptor Encephalitis.

Authors:  Yusuke Sakiyama; Eiji Matsuura; Ayano Shigehisa; Yuki Hamada; Mika Dozono; Satoshi Nozuma; Tomonori Nakamura; Keiko Higashi; Akihiro Hashiguchi; Yukitoshi Takahashi; Hiroshi Takashima
Journal:  Intern Med       Date:  2020-06-09       Impact factor: 1.271

5.  Simultaneous Development of Progressive Multifocal Leukoencephalopathy and Cryptococcal Meningitis during Methotrexate and Infliximab Treatment.

Authors:  Yasunobu Nosaki; Ken Ohyama; Maki Watanabe; Takamasa Yokoi; Kazuo Nakamichi; Masayuki Saijo; Yoshiharu Miura; Katsushige Iwai
Journal:  Intern Med       Date:  2019-09-15       Impact factor: 1.271

Review 6.  Bilateral lesions of the basal ganglia and thalami (central grey matter)-pictorial review.

Authors:  Sofie Van Cauter; Mariasavina Severino; Rosamaria Ammendola; Brecht Van Berkel; Hrvoje Vavro; Luc van den Hauwe; Zoran Rumboldt
Journal:  Neuroradiology       Date:  2020-08-05       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.